Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „monitoring“
Suchtreffer
Begriffe & Kennungen
RoActemra · 4.8 · Hepatic transaminase elevations During routine laboratory monitoring in the tocilizumab 12 month controlled cl
Eintrag öffnenRoActemra · 4.8 · Hepatic transaminase elevations During routine laboratory monitoring in the tocilizumab 6-month controlled cli
Eintrag öffnenRoActemra · 4.8 · Hepatic transaminase elevations During routine laboratory monitoring in the tocilizumab all exposure populatio
Eintrag öffnenRoActemra · 4.8 · Laboratory abnormalities During routine laboratory monitoring in the tocilizumab all exposure population, a de
Eintrag öffnenRoActemra · 4.8 · Laboratory abnormalities During routine laboratory monitoring in the tocilizumab all exposure population, a de
Eintrag öffnenRoActemra · 4.8 · Lipid parameters During routine laboratory monitoring in the 12 week controlled phase (Trial WA18221), 13.4 %
Eintrag öffnenRoActemra · 4.8 · Lipid parameters During routine laboratory monitoring in the intravenous tocilizumab Trial WA19977 3.4 % and 1
Eintrag öffnenRoActemra · 4.8 · Lipid parameters During routine laboratory monitoring in the tocilizumab 12 month controlled clinical trial, 3
Eintrag öffnenRoActemra · 4.8 · Lipid parameters During routine laboratory monitoring in the tocilizumab 12 month controlled clinical trial, 3
Eintrag öffnenRoActemra · 4.8 · Lipid parameters During routine laboratory monitoring in the tocilizumab 6 month controlled clinical Trial SC-
Eintrag öffnenRoActemra · 4.8 · Lipid parameters During routine laboratory monitoring in the tocilizumab 6-month controlled clinical Trial SC-
Eintrag öffnenRoActemra · 4.8 · Neutrophils During routine laboratory monitoring in the 12 week controlled phase, a decrease in neutrophil cou
Eintrag öffnenRoActemra · 4.8 · Neutrophils During routine laboratory monitoring in the tocilizumab 12 month controlled clinical trial, a decr
Eintrag öffnenRoActemra · 4.8 · Neutrophils During routine laboratory monitoring in the tocilizumab 12 month controlled clinical trial, a decr
Eintrag öffnenRoActemra · 4.8 · Neutrophils During routine laboratory monitoring in the tocilizumab 6 month controlled clinical Trial SC-I, a
Eintrag öffnenRoActemra · 4.8 · Neutrophils During routine laboratory monitoring in the tocilizumab 6-month controlled clinical Trial SC-I, a
Eintrag öffnenRoActemra · 4.8 · Platelets During routine laboratory monitoring in the 12 week controlled phase, 3 % of patients in the placebo
Eintrag öffnenRoActemra · 4.8 · Platelets During routine laboratory monitoring in the tocilizumab 12 month controlled clinical trial, one pati
Eintrag öffnenRoActemra · 4.8 · Platelets During routine laboratory monitoring in the tocilizumab 12 month controlled clinical trial, one pati
Eintrag öffnenRoActemra · 4.8 · Platelets During routine laboratory monitoring in the tocilizumab 6 month clinical Trial SC-I, none of the pat
Eintrag öffnen